 dollar industry. Statistical software for this industry is itself a significant business. We sell iBART both to drug company trialists and to federally sponsored clinical researchers. We expect iBART s tutorial and the Bayesian approach in general to appeal especially to the many trialists without specialized statistical qualifications. This proposal will investigate several
dollar industry. Statistical software for this industry is itself a significant business. We deal iBART both to drug ship's company trialists and to federally sponsored clinical researchers. We expect iBART s tutorial and the Bayesian approach path in general to appeal specially to the many trialists without specialized statistical qualification. This proposal will investigate several
 doplar industry. Statisticau software for jhus indnstry ia itself a significant business. We sxll uBART both to drug company grialists and to dedecally sponsored rminical reseadghers. Xe expect iBART s tutorian and the Bayevixn approach in general to appeal espesially yo the many triajistx witgout specialized statistical qualiricatiois. This proposak will investigate several
dollar industry. Statistical software for this industry a business. We iBART both to federally clinical researchers. We iBART s tutorial the Bayesian approach in general to especially to the many trialists without specialized statistical qualifications. This proposal will investigate
 dollar industry. Statistical Software foR this IndUstRy Is itSelf A significant buSInesS. We sell iBART both to drug CompaNy TRialIStS and tO federaLLy SPOnsOrEd CliNiCAl ReseaRchErs. We exPect iBART s TutOrIal and the BayESiAn approach In gEneral to appeAl eSpeciaLlY to THe manY trIalisTs withOUt specIalized stAtIStical QUalificATIoNs. ThIs proposal will invEStIGate several
 dollar industry. Statisti cal softwa re fo r t his  i ndus tryis itself a si g nifi cant business. We sell  iBAR Tb otht odrugcompany tr i a lis ts  a ndto fe deral lysponsor ed clinica l r es earchers. We ex pect iBART  stutorial and  th e Baye si ana pproa chin ge neralt o appe al especi al l y to t h e manyt r ia list s without special i ze d  statistical q ualifi ca t io n s . T his  proposalwi ll in v estigat e  s e v e ral 
 dollar_industry. Statistical_software for this industry_is itself_a_significant business._We_sell iBART both_to drug company_trialists and to federally_sponsored clinical researchers._We_expect iBART s tutorial and the Bayesian approach in general to appeal especially to_the_many trialists_without_specialized_statistical qualifications. This proposal will_investigate several